HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seizure after intrathecal baclofen bolus in a multiple sclerosis patient treated with oxcarbazepine.

Abstract
Epileptic seizures associated with intrathecal baclofen (ITB) application have been observed in patients with traumatic brain injury. A higher incidence of seizures has also been reported in patients with multiple sclerosis (MS) receiving ITB. To our knowledge, no case of a first epileptic seizure has been reported in the context of ITB bolus testing in MS. We report a 41-year-old female patient with primary progressive MS receiving olanzapine and oxcarbazepine for psychotic disorder. Five years prior she began to develop severe spastic quadriparesis, rendering her a candidate for ITB treatment. After ITB test bolus application, however, she experienced a first epileptic seizure. Our observation indicates that ITB may trigger seizures in patients with MS. The observed seizure occurred during ITB bolus testing despite antiepileptic co-medication, which concurs with previous reports suggesting that rapid changes in the dose of ITB may carry a higher risk of seizure induction.
AuthorsGiangaetano D'Aleo, Carmela Rifici, Markus Kofler, Edoardo Sessa, Leopold Saltuari, Placido Bramanti
JournalNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Neurol Sci) Vol. 32 Issue 2 Pg. 293-5 (Apr 2011) ISSN: 1590-3478 [Electronic] Italy
PMID20607336 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anticonvulsants
  • Antipsychotic Agents
  • GABA-B Receptor Agonists
  • Benzodiazepines
  • Carbamazepine
  • Baclofen
  • Olanzapine
  • Oxcarbazepine
Topics
  • Adult
  • Anticonvulsants (therapeutic use)
  • Antipsychotic Agents (therapeutic use)
  • Baclofen (administration & dosage, adverse effects, therapeutic use)
  • Benzodiazepines (therapeutic use)
  • Carbamazepine (analogs & derivatives, therapeutic use)
  • Female
  • GABA-B Receptor Agonists (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Injections, Spinal
  • Multiple Sclerosis, Chronic Progressive (drug therapy)
  • Olanzapine
  • Oxcarbazepine
  • Seizures (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: